Abstract
Colistin is an antibiotic of last resort for treating Gram-negative bacterial infections, but resistance is spreading rapidly. In a recent issue of Nature, Wang et al. use genome mining to identify and synthesize a natural variant that bypasses colistin resistance and offers new hope for tackling antimicrobial resistance.
Original language | English |
---|---|
Pages (from-to) | 273-274 |
Number of pages | 2 |
Journal | Cell Host & Microbe |
Volume | 30 |
Issue number | 3 |
DOIs |
|
Publication status | Published - 9 Mar 2022 |
Keywords
- anti-bacterial agents - pharmacology - therapeutic use
- drug resistance
- colistin - pharmacology - therapeutic use
- humans
- gram-negative bacterial Infections - drug therapy